Biologics Manufacturing Centre (BMC) Inc.
is interested in partnering up on the following tender opportunity:
Tender notice title: RFI Foot and Mouth Disease Vaccine Bank
Publication date 2023/07/06
Closing date and time 2023/08/11 14:00 EDT
Biologics Manufacturing Centre (BMC) Inc. details
GMP-CMO for cell-based biologics in-single use production
BMC a perfect GMP manufacturing partner for cell-based biologics production ranging from Vaccines (viral vector, protein subunit, virus-like particles) to diverse therapeutic proteins (antibodies, enzymes); and especially for phase 2/3 vaccines and therapeutic candidates maturing in late-stage clinical phases up to commercial approval. - 58,000 sq feet single-use, self-contained facility and with end-to-end production. - Cleanroom facility designed for biocontainment level 2 (CL2) and capable to handle from 50L up to 2000L biological material. - Storage warehouse under GMP and Good Distribution Practice conditions equipped to store at ambient (15-25°C) as well as refrigerated (2-8°C) or frozen (-60°C) with well controlled and monitored systems - GMP large scale Upstream/Downstream processes as well as QA/QC - Availability 24/7 - Located in Mtl near airport (YUL) and train
First name Sylvie
Last name Berthiaume
Director, Business Development and Marketing